IMN || Across Specialties

Hoarding: Not just a symptom of OCD

Posted on: 24/03/2014 - 21:05

ORLANDO – Compulsive hoarding traditionally has been considered virtually synonymous with obsessive-compulsive disorder, but its reach actually extends far beyond. Indeed, hoarding turns out to be...

Field of Interest: Geriatrics

Type: News Item

USPSTF: Evidence still ‘insufficient’ to back cognitive impairment screening

Posted on: 24/03/2014 - 21:00

Citing an ongoing lack of data about the benefits and harms of screening, the U.S. Preventive Services Task Force has left unchanged the recommendations of its 2003 guidelines on cognitive impairment...

Field of Interest: Geriatrics

Type: News Item

Oophorectomy did not eliminate uterine cancer risk in BRCA1 mutation carriers

Posted on: 24/03/2014 - 19:50

TAMPA – Women with BRCA1 mutations who undergo risk-reducing salpingo-oophorectomy may remain at risk for rare types of aggressive uterine cancer, according to preliminary findings from a prospective...

Field of Interest: Oncology

Type: News Item

Oophorectomy did not eliminate uterine cancer risk in BRCA1 mutation carriers

Posted on: 24/03/2014 - 19:50

Field of Interest: Pulmonology

Type: News Item

Novel agent for papulopustular rosacea found safe, effective in phase III trials

Posted on: 23/03/2014 - 19:50

DENVER – Ivermectin 1% cream applied once daily was effective and safe in treating patients with moderate to severe papulopustular rosacea, based on data from a pair of phase III studies. Ivermectin...

Field of Interest: Dermatology

Type: News Item

VIDEO: Ivermectin shows promise for treating papulopustular rosacea

Posted on: 23/03/2014 - 18:40

DENVER – A limited number of safe and effective topical medications are currently available to treat chronic papulopustular (inflammatory) rosacea. In a <link...

Field of Interest: Dermatology

Type: News Item

FDA approves PDE-4 inhibitor for treating psoriatic arthritis

Posted on: 21/03/2014 - 21:50

Apremilast, an oral phosphodiesterase-4 inhibitor, has been approved for treating adults with active psoriatic arthritis, based on the results of three studies of 1,493 patients, the Food and Drug...

Field of Interest: Dermatology

Type: News Item

FDA approves PDE-4 inhibitor for treating psoriatic arthritis

Posted on: 21/03/2014 - 21:50

Apremilast, an oral phosphodiesterase-4 inhibitor, has been approved for treating adults with active psoriatic arthritis, based on the results of three studies of 1,493 patients, the Food and Drug...

Field of Interest: Rheumatology

Type: News Item

FDA approves omalizumab for chronic idiopathic urticaria

Posted on: 21/03/2014 - 21:30

The Food and Drug Administration has approved omalizumab (Xolair) for chronic idiopathic urticaria in people 12 years of age and older who remain symptomatic despite treatment with...

Field of Interest: Dermatology

Type: News Item

Treatment decisions complex for pregnant, postpartum women with bipolar disorder

Posted on: 20/03/2014 - 15:10

The clinical features of perinatal women with bipolar disorder are much more severe than those of women seeking care for other psychiatric conditions, including greater history of suicidal behavior...

Field of Interest: Pulmonology

Type: News Item

« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »

Newsletters

Stay informed on our latest news!

Latest Newsletters

randomness

You are here

Newsletters

Latest Newsletters